Skip to main content

Table 5 Body weight, hematological and non-hematological data follow-up for patients taking chemotherapy plus A. cinnamomea (AC) or placebo

From: A preliminary randomised controlled study of short-term Antrodia cinnamomea treatment combined with chemotherapy for patients with advanced cancer

 

Chemotherapy + AC (n = 17)

p-valuea

Chemotherapy + placebo (n = 20)

p-valuea

p-valueb

Pre-test

Post-test

Pre-test

Post-test

Hematological

 WBC (103/ul)

6.1 ± 2.64

11.55 ± 1.30

0.38

5.75 ± 3.23

11.47 ± 1.48

0.34

0.10

 Hemoglobin (g/dl)

11.57 ± 1.17

6.17 ± 2.77

0.43

11.75 ± 2.03

5.69 ± 2.16

0.77

0.79

 Platelet (103/ul)

179.11 ± 65.11

141.71 ± 63.47

<.001

201 ± 68.97

196.55 ± 74.47

0.33

0.02

 Non-hematological

Bilirubin (mg/dl)

0.64 ± 0.17

0.79 ± 0.78

0.48

0.49 ± 0.19

0.62 ± 0.28

0.12

0.62

 AST (u/l)

37.88 ± 22.01

39.62 ± 26.38

0.33

27.75 ± 11.68

26.50 ± 9.73

0.30

0.07

 ALT (u/l)

29.70 ± 17.50

28.70 ± 15.46

0.14

20.33 ± 10.28

29.89 ± 9.46

0.42

0.09

 Creatinine (mg/dl)

0.82 ± 0.29

0.86 ± 0.30

0.11

0.72 ± .17

0.78 ± 0.17

0.10

0.73

 Body weight (kg)

61.98 ± 9.09

61.24 ± 9.13

0.21

60.36 ± 11.11

59.45 ± 11.36

0.13

0.53

  1. aWilcoxon signed-rank test (Within group)
  2. bMann-Whitney U test (Differences in efficacy between two groups